Conférences - Pharmacologie et développement des médicaments - États-Unis

Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

1.
 
CGT World — Cell & Gene Therapy World
ID
844931
Dates
18 jan 2017 - 20 jan 2017
Lieu
Miami, États-Unis
Contact
Carina Hunter;     Tél.: [+44(0)2073847897];     Email.: team@phacilitate.co.uk
Sujets
cell therapy, gene therapy, clinical trials, regulatory, cord blood, bioprocessing, r&d, strategic
2.
 
Immuno World 2017 — Immunotherapy World 2017
ID
845007
Dates
18 jan 2017 - 20 jan 2017
Lieu
Miami, États-Unis
Résumé
After years of posting impressive clinical results and pushing analyst projections to greater and greater heights, immuno-oncology has solidified its status as the most exciting development in cancer treatment for a long time. Now that checkpoint inhibitors have uncloaked cancer cells, drug developers are investigating dozens of immune drug cocktails (everything from CAR-T to antibodies, vaccines and other cellular therapies) to find well-tolerated treatments which could become the first-in-line to fight cancer in patients.
Contact
Carina Hunter;     Tél.: [+44(0)2073847897];     Email.: team@phacilitate.co.uk
Sujets
immuno, immunotherapy, oncology, R&D, regulatory, supply chain, logistics, lab sessions,
Sujets apparentés
3.
 
Keystone Symposia: Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies
ID
830128
Dates
22 jan 2017 - 26 jan 2017
Lieu
Snowbird, Utah, États-Unis
Résumé
The purpose of this meeting is to examine different approaches for treatment of cancer and other diseases (e.g., fibrosis, autoimmunity and inflammatory diseases). The program will provide insights from academic and industry scientists on innovative biologics technologies and treatment strategies for ameliorating disease in an effort to identify synergies and opportunities to cross-fertilize approaches. Furthermore, the meeting includes perspectives from the US Food & Drug Administration and how the outlined strategies will impact the drug review and approval process. The intention is to better inform meeting attendees of current/future strategies for treating disease and best practices for transforming concepts into approved drugs.
Contact
Attendee Services;     Tél.: [970-262-1230 or 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
Cancer, drug discovery, immunology
4.
 
FDA Scrutiny of Promotion and Advertising Practices
ID
852544
Dates
24 jan 2017 - 25 jan 2017
Lieu
San Francisco, États-Unis
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
fda's advertising and promotion requirements, fda regulations for labelling, fda warning letter, fda legal authority, ftc, mass media, doj, off label, fda guidance, custom device promotion, fda compliance seminar
5.
 
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions
ID
855320
Dates
26 jan 2017 - 27 jan 2017
Lieu
Orlando, États-Unis
Résumé
Raw material requirements in a cGMP environment are often overlooked as a company develops new products. Depending on the product being developed, e.g., tablets and capsules vs. biotechnology products, as few as fifteen to twenty or as many as sixty raw materials need to be sourced before the process can be moved from initiation through completion.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Raw material requirements in a cgmp environment training, compendial and non-compendial testing, ASQ on sample size, ICH Q9
6.
 
Latin America: Regulatory Compliance Requirements for Life Science Products (Focus: Brazil, Mexico, Argentina)
ID
855418
Dates
26 jan 2017 - 27 jan 2017
Lieu
San Francisco, États-Unis
Résumé
This two-day comprehensive Course on Latin America Regulatory compliance requirements will cover topics ranging from pre-clinical and clinical requirements through product registration, amendments and renewals across Pharmaceuticals, Biologics, Medical Devices and Combination Products. The Course will address the structure of the regulatory agencies in Latin America and discuss local cultural nuances to help you be successful in working with the regulators.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Latin America regulations, Latin America life sciences regulations, Latam life sciences regulatory requirements, Latin America pharmaceutical regulations, Latin America medical device regulations, Latin America biologics regulations
7.
 
Supplier and Contractor Qualification and Control for Life Science Industry
ID
855406
Dates
26 jan 2017 - 27 jan 2017
Lieu
Tampa, États-Unis
Résumé
This two-day course focuses on the processes associated with the acquisition of products, materials and services that fuel and support the organization’s product manufacturing and marketing. These cross-functional processes are complex and result in conflicting objectives between decision-makers. Management is responsible for organizing and providing resources and the more they understand, the more effectively they can manage. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Supplier control program, contractor qualification, Part 211, subpart e-control, drug product containers, ICH Q7A, section VII, materials management part 820
8.
 
Essentials Of USP Microbiology - Reading Between the Lines of the USP General and Information Microbiology Chapters
ID
855350
Dates
31 jan 2017 - 01 fév 2017
Lieu
Orlando, États-Unis
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
USP Microbiology, USP microbiology chapters, USP general, USP General Chapter Changes, USP Chapters, USP document, HVAC, USP, EP and JP
9.
 
Navigating the Maze for Post-Market Compliance -- Complaint Handling, MDRs, Recalls and Proposed Guidance on FDA Risk Benefits
ID
868096
Dates
02 fév 2017 - 03 fév 2017
Lieu
Tampa, États-Unis
Résumé
This interactive one and a half day course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief, who has more than 36 years’ experience with the FDA will provide the participants tools to minimize risk of regulatory enforcement actions.

During the seminar, Ms. Hoffman will explain proper handling of complaints reportable or non-reportable, product complaint handling and documentation, how and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall. She will also discuss how to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA.Note:Use coupon code NB5SQH8N and get 10% off on registration.

Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
medical device recalls seminar, medical device regulations seminar, medical device reporting, medical device complaint management, medical device complaint handling
10.
 
Compliance Risk Management in Medical Devices, Pharmaceuticals, and Combination Products
ID
868117
Dates
02 fév 2017 - 03 fév 2017
Lieu
Tampa, États-Unis
Résumé
Effective risk management is the hallmark of a successful corporation. Increasingly, it is also the hallmark of a compliant corporation. While Medical Devices, Pharmaceuticals, and Combination Products have had unique histories for the evolution of risk management, the management of compliance risk is a common business process for all three areas.Enterprise Risk Management (ERM) is the generic term for managing the risks of an organization. ISO 31000 is the ERM ISO Standard. This standard provides guidance for organizations on implementing ERM solutions. ISO 9001 is the Quality Systeme Standard. ISO 9001 now requires to establish “risk-based thinking.” As a result, ISO 13485, the International Quality System Standard for Medical Devices, has been revised to include requirements for firms to implement Compliance Risk Management. These requirements are in addition to the requirements as currently defined by ISO 14971, the International Standard for Risk Management of Medical Devices.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Enterprise Risk Management (ERM) Training, ISO 31000, ERM solutions, ISO 14971 Training, medical device risk management training
11.
 
9ITIM — 9th Immunotherapeutics & Immunomonitoring Conference
ID
854237
Dates
06 fév 2017 - 07 fév 2017
Lieu
San Diego, États-Unis
Résumé
GTCbio is proud to present the 9th Immunotherapeutics & Immunomonitoring Conference, to be held on February 6-7, 2017 in San Diego, CA.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Immunotherapy, Immune therapeutics. Immunotherapeutics, Immunomonitoring, Immunodiagnostics
12.
 
7th Ubiquitin Research & Drug Discovery Conference
ID
855580
Dates
08 fév 2017 - 09 fév 2017
Lieu
San Diego, États-Unis
Résumé
We are pleased to invite you to GTCbio's 7th Ubiquitin Research & Drug Discovery Conference, which will take place February 8-9, 2017 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with deubiquitinating enzymes, and novel drug targets in the ubiquitin system will be covered. Please join us not only for updates on the latest scientific research, but also for networking sessions between colleagues from both industry and academia in order to get the most comprehensive exchange of ideas.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
13.
 
3rd Protease Inhibitors in Drug Discovery Conference
ID
855645
Dates
08 fév 2017 - 09 fév 2017
Lieu
San Diego, États-Unis
Résumé
We are pleased to announce the 3rd Protease Inhibitors in Drug Discovery Conference, to be hosted by GTCbio on February 8-9, 2017 in San Diego, CA. Though protease inhibitors hold great therapeutic promise in areas such as inflammation, cardiovascular diseases, and cancer, researchers in the field are still overcoming the challenge of specificity for drug design. This meeting will provide a forum for scientists from both industry and academia to share recent advances in protease inhibitor research, from biological functions to translational aspects for drug discovery. Speakers will cover topics such as regulation of proteases by exosites, drug design of protease inhibitors, membrane-associated proteolysis, and many more. In addition to cutting-edge scientific presentations, attendees will be able to form new connections during dedicated networking sessions.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
14.
 
SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations
ID
868072
Dates
09 fév 2017 - 10 fév 2017
Lieu
Scottsdale, États-Unis
Résumé
One of the best ways to ensure that an organization meets its regulatory obligations is to follow SOPs. SOPs are standardized procedures and processes prepared with enough detail to ensure that tasks are performed consistently each time they are done. SOPs are also required to be in compliance with regulations and guidelines internationally, across all regulated functions. Lack of SOPs and not following SOPs are often cited in regulatory inspections as deficiencies that must be corrected. Poorly prepared SOPs or poor compliance with existing SOPs can compromise a drug development program, an effective quality system, and may result in product recalls.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
FDA SOP requirements, FDA SOPs, FDA regulated industry SOP types, FDA SOP components, SOP training, SOP implementation, SOP template, SOP numbering system
15.
 
Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)
ID
868148
Dates
09 fév 2017 - 10 fév 2017
Lieu
Burlingame, États-Unis
Résumé
Analytical methods and procedures should be validated to ensure reliability, consistency and accuracy of analytical data. Compendial methods should be verified to demonstrate the suitability of laboratories to successfully run the method and when methods are transferred between laboratories successful transfer should be demonstrated through testing. In case a laboratory wants to use an alternative method instead of a compendial method, equivalency of the alternative method to the compendial method should be demonstrated.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Laboratory compliance, Analytical methods, data, procedures, compendial methods, Method validation and transfer, equivalency testing, FDA inspection
16.
 
FDA Recalls - Before You Start, and After You Finish
ID
868103
Dates
09 fév 2017 - 10 fév 2017
Lieu
San Jose, États-Unis
Résumé
FDA's recall authority and program launches you into a project of crisis management. You will learn how to establish a roadmap for conducting recalls. The knowledge you gain will sharpen your recall management decisions and strategy. You will learn how to use the FDA's health risk criteria so you can develop effective recall procedures. One critical aspect of recalls involves the identification of the root cause of the recall and how you could or should prevent that problem from happening again. Your corrective and preventive action program (CAPA) and quality assurance functions require a rigorous approach to prevent a chronic history of recalls. Reiterative recalls lead the FDA to the conclusion that,
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
FDA Recall, FDA recall classes, FDA recall guidance, FDA recall procedures, regulatory management, CAPA, FDA inspection, Recall Regulations
17.
 
11th ANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE
ID
842993
Dates
12 fév 2017 - 14 fév 2017
Lieu
San Diego, Californie, États-Unis
Résumé
This didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug.
Contact
Sara Classen;     Tél.: [Tel: +1.212.901.8009];     Email.: sclassen@alzdiscovery.org
Sujets
Neurodegeneration, Drug discovery, CNS, Alzheimer’s Disease
18.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811327
Dates
20 fév 2017 - 22 fév 2017
Lieu
Baltimore, États-Unis
Résumé
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Contact
James Martin;     Tél.: [1-302-231-6959];     Email.: Vaccines@madrige.com
Sujets
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
Sujets apparentés
19.
 
Frontiers in Cancer Immunotherapy
ID
824447
Dates
27 fév 2017 - 28 fév 2017
Lieu
New York, NY, États-Unis
Résumé
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Sujets
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
20.
 
Chemical Development & Scale-Up in the Fine Chemical & Pharmaceutical Industries
ID
858611
Dates
01 mar 2017 - 03 mar 2017
Lieu
Pasadena, California, États-Unis
21.
 
Seminar on the DHF, Technical File and Design Dossier - Similarities, Differences and the Future
ID
857612
Dates
02 mar 2017 - 03 mar 2017
Lieu
Las Vegas, NV, États-Unis
Contact
Event Manager;     Tél.: [(800) 447-9407];     Email.: support@globalcompliancepanel.com
Sujets
The Design History File, Device History Record, The Device Master Record, EU’s Medical Device Directive, Technical File Design Dossier, U.S. FDA’s DHF, FDA Compliance, FDA Regulations, Risk Analysis, Risk Management
22.
 
Keystone Symposia - Kinases: Next-Generation Insights and Approaches
ID
825388
Dates
05 mar 2017 - 09 mar 2017
Lieu
Breckenridge, Colorado, États-Unis
Résumé
Decades of both basic and applied research have unequivocally established the importance the kinase family of phosphotransferase enzymes in virtually every aspect of organismal homeostasis. From the initial characterization of ATP-dependent phosphorylation in the liver by Gene Kennedy in 1954, our understanding of the family has grown from the diverse perspectives of enzymology, biochemistry, biophysics, structural biology, genetics, cellular biology, pharmacology and physiology. Importantly, these advancements have yielded transformative therapeutic approaches to disease, most notably in the field of cancer where kinase inhibition is helping to fulfill the promise of precision medicine. Yet even today, our perspectives on the complexity of this class of enzymes continues to evolve, and many of the most exciting advancements in the field are being made by applying modern-day insights and technological approaches to the diverse roles the enzymes can play in health and human disease. This meeting will be devoted to exploring this innovative leading edge of kinase research, and will bring together leading researchers from academic, clinical and pharmaceutical settings to explore and define the new horizons in the field of kinase biology.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
Kinases, Drug Discovery, Kinase Signaling, Kinase Inhibitor
23.
 
Keystone Symposia - Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
ID
825246
Dates
19 mar 2017 - 22 mar 2017
Lieu
Tahoe City, California, États-Unis
Résumé
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
sex, gender, metabolic homeostasis, diabetes, obesity, sex differences, estrogens, androgen, drug design, gender-specific medicine, metabolomics, genetics
Sujets apparentés
24.
 
8th Annual Biotherapeutics Analytical Summit
ID
829772
Dates
20 mar 2017 - 23 mar 2017
Lieu
Bethesda, États-Unis
Résumé
Today’s complex biologics formats and ever increasing regulatory demands necessitates that companies come up with the most efficient, accurate and robust analytical methods to characterize a molecule; find the most effective tools to assess the molecule’s physico-chemical properties to optimize its druggability and developability, and to ensure that the end product is consistently safe and efficacious when comparing between batches or between biosimilars and innovators. When it comes to batch-to-batch variation, as the saying goes, “process is the product” – process analytics and quality control are thus of biggest concern to manufacturers and regulators alike.
Contact
Bethany Gray;     Tél.: [781-972-5400];     Email.: chi@healthtech.com
25.
 
Keystone Symposia - HIV Vaccines
ID
825181
Dates
26 mar 2017 - 30 mar 2017
Lieu
Steamboat Springs, Colorado, États-Unis
Résumé
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Sujets apparentés
26.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825397
Dates
01 mai 2017 - 04 mai 2017
Lieu
Estes Park, Colorado, États-Unis
Résumé
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Sujets apparentés
27.
 
E&L USA 2017 — Extractables & Leachables USA 2017
ID
854305
Dates
09 mai 2017 - 11 mai 2017
Lieu
Falls Church, VA, États-Unis
Résumé
Extractables and leachables examination is continuously growing in importance. Given the current scruitny paid by governing bodies including the FDA and EMEA, understanding the best practice and guidelines to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.
Contact
Emma Nweton;     Tél.: [+44 (0) 1372 802016];     Email.: enewton@smithers.com
Sujets
extractables, leachables, analytical chemistry, pharmaceuticals, drug development, drug delivery, regulations, quality assurance, single-use systems, risk assessments, packaging, drug packaging
28.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858817
Dates
13 jui 2017 - 15 jui 2017
Lieu
Chicago, États-Unis
29.
 
9th International Conference and Exhibition on Pharmacovigilance & Drug Safety
ID
869742
Dates
17 jul 2017 - 19 jul 2017
Lieu
Munich, États-Unis
Contact
programe cordinator;     Tél.: [702-508-5200];     Email.: pharmacovigilance@pharmaceuticalconferences.org
Sujets
Advanced Regulatory Compliance in Pharmacovigilance operations and innovations Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
30.
 
International Vaccines Congress
ID
857257
Dates
27 jul 2017 - 28 jul 2017
Lieu
Chicago, États-Unis
Résumé
PULSUS is the publisher of peer reviewed scientific, technical, and medical journals and magazines. Since establishment 1984, has been instrumental in healthcare and medical dissemination. PULSUS expanded with the support from scientific societies and open its arm to conduct global medical and healthcare meetings. With immense please and support, PULSUS is honored to announced it International Vaccines Congress, which will be going to held in Chicago, USA during July 27-28, 2017.
Contact
Annah Brwon;     Email.: vaccinescongress@protonmail.com
Sujets
vaccines Congress, Vaccines Conference 2017, Vaccines Conference USA
Sujets apparentés
31.
 
Pharmacology Studies 2017 — International Conference on Pharmacology & Toxicology Studies
ID
859573
Dates
07 aou 2017 - 09 aou 2017
Lieu
Philadelphia, États-Unis
Résumé
Scientific Synergy Conferences are delighted to welcome you all to the
Contact
Scientific Synergy;     Tél.: [+1-888-623-5051];     Email.: pharmacology@scientificsynergy.com
Sujets
Pharmacology Studies 2017, Pharmacology Conference, Toxicology Conference, Scientific Synergy USA, Pharmacology Conference Philadelphia, Pharmacology Congress USA, Clinical Pharmacology event, Drug Toxicology, Pharmacology Case Reports, Forensic Toxicology.
32.
 
ICCP — 5th International Conference on Clinical Pharmacy
ID
858226
Dates
23 oct 2017 - 24 oct 2017
Lieu
Florida, États-Unis
Résumé
Clinical Pharmacy Conference aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results about all aspects of Clinical Pharmacy. It also provides the disciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Clinical Pharmacy. All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers, and e-posters. Also, high-quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Clinical Pharmacy are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers, and e-posters that address themes and topics of the conference, including figures, tables, and references of novel research material. The conference abstracts and proceedings book and certificate of presentation will be distributed to the conference participants at the conference registration desk. In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of biomedical, pharmaceutical, and clinical sciences by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Clinical Pharmacy.
Contact
Victor Badoni;     Tél.: [7025085200 Ext: 8047];     Email.: badonivictor@outlook.com
Sujets
Pharma Conferences, Pharmacy Conferences, Clinical Pharmacy Conferneces, Pharmaceutical Conferences
33.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858873
Dates
31 oct 2017 - 02 nov 2017
Lieu
Boston , États-Unis
34.
 
Biomarkers congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
867795
Dates
27 nov 2017 - 28 nov 2017
Lieu
Atlanta, États-Unis
Résumé
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact
Rachel Mathews;     Email.: america@cmesociety.com
Sujets
Biomarkers Conference, Biomarkers Conference 2017, Biomarkers Conference December, Cancer Biomarkers, Cancer Conferences, Cancer Conferences 2017, Biomarkers Events, Biomarkers Society Conferences, Biomarkers Congress
Sujets apparentés

États-Unis: liste de tous les évènements/conférences.

Pre-Filled Syringes Europe
RNA Therapeutics conference
Superbugs & Superdrugs Conference

Bon à savoir...

Vous pouvez insérer un encadré afin de diffuser vos évènements et services dans cet espace.

Dernière mise à jour: 15 Janvier 2017